Michael G. Malkowski,
Ph.D
Hauptman-Woodward Institute - Senior Research Scientist
Assistant Professor of Structural Biology, SUNY Buffalo EDUCATION
B.Sc., Biochemistry, University of Detroit, Detroit, MI, 1991
Ph.D., Biochemistry, Wayne State University, Detroit, MI, 1997 |
|
Research Interests
Crystallographic characterization and functional analysis of integral
membrane enzymes involved in lipid metabolism; fatty acid desaturation;
enzymatic mechanisms of fatty acid oxygenation; development of tools
for high-throughput structural characterization of membrane proteins.
The Structural Biology of Oxylipin Biosynthesis
Public perception of healthy food and lifestyle, as well as the identification
of specific biological roles in certain clinical conditions, has brought
a renewed attention to polyunsaturated fatty acids (PUFAs) with respect
to health and disease. PUFAs are lipid molecules that differ in
hydrocarbon length and degree of saturation. These essential fatty
acids cannot be synthesized de novo by most eukaryotic organisms and
therefore must be obtained from dietary sources. Once ingested,
PUFAs are acted upon by desaturase and elongase enzymes, which form a
larger family of precursors that play a key role in maintaining the fluidity
and structural integrity of all cell membranes. PUFAs play an equally
significant role as signaling molecules in numerous biologically vital
pathways. However, in order to exert their full range of biological
effects, PUFAs are generally metabolized into more potent substances
called oxylipins. The term “oxylipin” is used collectively
to refer to oxygenated, 18-22 carbon PUFA-based compounds that are biosynthesized
through the stereospecific addition of one, two, or four atoms of oxygen
at different carbon positions, followed by subsequent conversion of the
developing peroxide or hydroperoxide intermediate into a stable, biologically
active compound. Arachidonic acid (AA; 20:4 w-6) is the most vital
PUFA precursor of the eicosanoid class of oxylipins in animals. The “arachidonate
cascade”, which is comprised of the cyclooxygenase, lipoxygenase,
and epoxygenase pathways, is responsible for the production of prostaglandins,
leukotrienes, lipoxins, hydroxy-, and epoxy- eicosatetraenoic acids. These
potent lipid signaling molecules are synthesized and released rapidly
in response to extracellular stimuli, where they play an important role
in a number of physiological processes. Moreover, they play a major
role in a vast array of inflammatory disorders such as asthma,
rheumatoid arthritis, atherosclerosis, and can be linked to other diseases
that are associated with inflammation including cardiovascular disease,
Alzheimer's disease, and cancer.
The major focus of my research is to use biochemical analyses, biophysical
tools, and x-ray crystallographic methods to understand how different
classes of integral membrane enzymes carry out stereoselective oxygenations
to generate unique oxylipins from a defined set of PUFA substrates. To
gain insight on the chemical determinants that drive stereoselective
oxygenation of PUFAs at the molecular level, we are studying different
integral membrane enzymes involved in oxylipin production in plants,
animals, and invertebrates.
Understanding the Stereoselective Oxygenations of AA by Aspirin-Acetylated
COX-2
Our goal is to understand the molecular mechanism
by which Cyclooxygenase-2 (COX-2) stereospecifically oxygenates AA
to form "novel" (15R)-prostaglandins
(15R-PGs). COX-1 and COX-2 catalyze the committed step in PG biosynthesis
and are the pharmacological targets of aspirin and other nonsteroidal
anti-inflammatory drugs (NSAIDs), which provide relief from the inflammation,
swelling, and pain associated with arthritis. In contrast to all
other NSAIDs, aspirin covalently modifies COX-1 and COX-2 via the acetylation
of a critical serine residue within the cyclooxygenase active site, resulting
in complete inhibition of PG biosynthesis. However, aspirin acetylation
of COX-2 results in a shift in the reaction specificity of the enzyme,
converting it from a cyclooxygenase to a lipoxygenase, resulting in the
formation of (15R)-hydroxyeicosatetraenoic acid (15R-HETE). 15R-HETE
is converted by downstream enzymes into (15R)-epi lipoxin, an aspirin-triggered
lipid mediator with potent anti-inflammatory actions. We are using
a combination of site-directed mutagenesis, functional analyses, and
x-ray crystallographic methods to test the hypothesis that the inversion
of stereochemistry at carbon-15 observed in products formed by aspirin
acetylated COX-2 is a result of AA binding in an "unconventional" conformation
within the cyclooxygenase active site prior to the initiation of catalysis. These
studies will provide for a complete mechanistic understanding of how
15R-PGs (and ultimately aspirin-triggered lipoxins) are generated, lend
valuable insight into how COX enzymes stereospecifically control oxygenation
during catalysis, and lead to further exploration and development of
new or combined therapeutic approaches for the treatment of arthritis,
with fewer unwanted side effects.
Characterizing the Structural Determinants Involved in the Stereoselective
Oxygenation of 18-Carbon PUFAs by Pathogen Inducible Oxygenase (PIOX),
a Plant Fatty Acid Alpha Dioxygenase Pathogen-Induced Oxygenase (PIOX) is a heme-containing, membrane-associated
protein found in mono- and dicotyledon plats that utilizes molecular
oxygen to convert the PUFAs linoleic acid and alpha linolenic acid
into their corresponding 2R-hydroperoxides. PIOX, which is a key
component of the host-defense response in plants, is a member of a larger
family of fatty acid alpha dioxygenases that includes mammalian COX-1
and COX-2. Many residues crucial for activity in mammalian COX
are conserved in PIOX. These residues include the distal and proximal
histidine residues involved in heme binding, and a catalytic tyrosine,
which is responsible for the initiation of catalysis. While there
are global differences between PIOX and COX enzymes with respect to their
potential overall structural architecture, substrate specificities, and
signaling pathways, the mechanism by which these enzymes stereoselectively
oxygenate PUFAs are strikingly similar. Our goal is to elucidate
the structure of PIOX and determine the mechanism controlling catalysis. This
information will enhance the existing knowledge of how PUFAs are stereoselectively
oxygenated and provide useful insights into other systems, which discriminate
between the saturation and chain length of a PUFA substrate. |